September is Prostate Cancer Awareness Month. More than 190,000 men will be diagnosed with prostate cancer this year, making it the second most common cancer among men. There is a 50 - 60% increased risk for African-American men.
Immunotherapy is an approved treatment method for those with advanced stage cancer. In a new trial, all men benefited from immunotherapy, but African American men lived over 4.5 years compared with 2.5 years for Caucasian men – a difference of more than 20 months and a nearly 50% reduction in the risk of death.
Chesapeake Urology offers personalized treatment plans and has several convenient locations. Learn more here.
